Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
31.77
+0.62 (1.99%)
At close: Apr 14, 2026, 4:00 PM EDT
31.77
0.00 (0.00%)
After-hours: Apr 14, 2026, 7:00 PM EDT

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
36,99335,88624,99011,70410,1328,838
Market Cap Growth
110.63%43.60%113.51%15.51%14.65%-16.48%
Enterprise Value
50,70849,42840,11629,25129,68631,098
Last Close Price
31.7731.2122.0410.449.128.01
PE Ratio
25.7425.79-15.20-20.88-4.1521.08
Forward PE
11.6212.078.354.213.633.02
PEG Ratio
2.781.826.690.401.630.68
PS Ratio
2.152.081.510.740.680.56
PB Ratio
4.534.544.651.561.300.86
P/TBV Ratio
4.684.594.641.561.300.86
P/FCF Ratio
32.2631.2633.3613.909.7237.45
P/OCF Ratio
22.4621.7620.048.566.3711.07
EV/Sales Ratio
2.942.862.421.851.991.96
EV/EBITDA Ratio
10.2415.6553.0618.44-33.3910.21
EV/EBIT Ratio
12.8322.92-132.4067.55-13.5118.12
EV/FCF Ratio
44.1743.0653.5634.7428.49131.77
Debt / Equity Ratio
2.162.163.162.482.512.09
Debt / EBITDA Ratio
5.415.4123.9112.71-24.257.70
Debt / FCF Ratio
14.8914.8924.1423.9420.6999.40
Net Debt / Equity Ratio
1.711.712.752.262.402.07
Net Debt / EBITDA Ratio
4.284.2919.5510.67-21.106.99
Net Debt / FCF Ratio
11.7911.7919.7320.1018.0090.23
Asset Turnover
0.430.430.400.360.330.32
Inventory Turnover
2.692.692.412.092.082.02
Quick Ratio
0.540.540.500.540.570.61
Current Ratio
1.041.040.981.021.051.14
Return on Equity (ROE)
20.57%20.58%-28.31%-7.38%-25.40%4.01%
Return on Assets (ROA)
6.17%6.18%-1.12%0.98%-3.82%2.37%
Return on Invested Capital (ROIC)
8.02%8.03%-1.43%1.21%-4.51%2.73%
Return on Capital Employed (ROCE)
8.01%8.02%-1.05%1.36%-6.35%4.63%
Earnings Yield
3.81%3.88%-6.58%-4.79%-24.12%4.74%
FCF Yield
3.10%3.20%3.00%7.19%10.28%2.67%
Buyback Yield / Dilution
-2.83%-2.83%-1.07%-0.81%-0.27%-1.10%
Total Shareholder Return
-2.83%-2.83%-1.07%-0.81%-0.27%-1.10%
Updated Jan 28, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q